We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Industry Urges FDA to Relax Hydrocodone Upscheduling for Low-Dose Drugs
Industry Urges FDA to Relax Hydrocodone Upscheduling for Low-Dose Drugs
The FDA’s proposal to establish tighter controls on hydrocodone combination drug products such as Vicodin should only apply to doses 5 mg or higher, drugmakers say.